<![CDATA[Genmab - Video abot the Lyra study]]>"Dr Habte Yimer speaks to ecancer at ASH 2018 about the Lyra study, a phase II study that uses daratumumab (dara) plus cyclophosphamide, bortezomib, and dexamethasone (CyBorD) to treat newly diagnosed and relapsed patients with multiple myeloma (MM)"

]]>https://dev.proinvestor.com/forum/topic/440012/genmab-video-abot-the-lyra-studyRSS for NodeThu, 16 Jul 2026 23:55:54 GMTMon, 17 Dec 2018 16:48:42 GMT60